The START Center for Cancer Research announced the launch of the START Hope Hub, a digital platform providing access to over 720 active oncology clinical trials. Designed for patients, physicians, and ...

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine ...

About ONCOLife. ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ...

The results from ATOMIC trial, presented at ASCO 2025, show that adding atezolizumab (Tecentriq) to FOLFOX chemotherapy halved the risk of recurrence or death in stage III dMMR colon cancer, boosting ...

ONCOLife presents an exclusive interview with Nick Slack, Chairman and CEO of The START Center for Cancer Research. In this session, we explore how the integration of the Carolina Urologic Research ...

We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...

The START Center for Cancer Research dosed the first U.S. patient in Moderna’s Phase 1 trial of mRNA-4106, a multivalent mRNA-based cancer vaccine targeting advanced solid tumors. The study evaluates ...

Ariceum Therapeutics announced that the US FDA has cleared its investigational new drug (IND) application to commence a Phase I/II clinical trial of its proprietary radiolabelled peptide, 225Ac-SSO110 ...

OneOncology aims to change that “OneOncology’s core mission has always been to elevate the standard and reach of community oncology care. Working with START allows our partner practices to extend ...

Johnson & Johnson’s Oncology Care Index reveals 73% of oncologists see a gap between new cancer treatments and clinical implementation, while 75% feel overwhelmed by rapid innovation. Nearly half seek ...